和誉医药股价年内涨幅高达280%，获国内外券商高度认可！_老虎社区_美港股上老虎

和誉医药股价年内涨幅高达280%，获国内外券商高度认可！

和誉医药
09-24 11:30

自年初以来， $和誉-B(02256)$ 在产品管线推进与商业合作方面连续取得重大突破，获得国内外资本市场高度认可，先后被纳入明晟公司（MSCI）全球小盘股指数成分股和富时（FTSE）中国小盘股指数，多家权威机构陆续发布看好报告！

小誉梳理了今年以来的机构评级，清一色“买入”、“增持”、“跑赢大市”等积极评价～资本市场一致看好，未来可期！

$和誉-B(02256)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":481938303836936,"tweetId":"481938303836936","gmtCreate":1758684643030,"gmtModify":1758684648874,"author":{"id":4143269081778110,"idStr":"4143269081778110","authorId":4143269081778110,"authorIdStr":"4143269081778110","name":"和誉医药","avatar":"https://static.tigerbbs.com/adb09e4e1f90e3f4deff5b93da1d691a","vip":5,"userType":5,"introduction":"和誉-B（2256.HK）专注于肿瘤创新药物研发，致力于改善中国及全球病人的生活质量。 ","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1643,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/39c4c957e073c98b90e7a378266e1202","width":"5760","height":"3240"}],"coverImages":[{"img":"https://static.tigerbbs.com/39c4c957e073c98b90e7a378266e1202","width":"5760","height":"3240"}],"title":"和誉医药股价年内涨幅高达280%，获国内外券商高度认可！","html":"<html><head></head><body>自年初以来， <a href=\"https://laohu8.com/S/02256\">$和誉-B(02256)$</a> 在产品管线推进与商业合作方面连续取得重大突破，获得国内外资本市场高度认可，先后被纳入明晟公司（MSCI）全球小盘股指数成分股和富时（FTSE）中国小盘股指数，多家权威机构陆续发布看好报告！\n小誉梳理了今年以来的机构评级，清一色“买入”、“增持”、“跑赢大市”等积极评价～资本市场一致看好，未来可期！\n<img src=\"https://static.tigerbbs.com/39c4c957e073c98b90e7a378266e1202\" tg-width=\"5760\" tg-height=\"3240\">\n<a href=\"https://laohu8.com/S/02256\">$和誉-B(02256)$</a></body></html>","htmlText":"<html><head></head><body>自年初以来， <a href=\"https://laohu8.com/S/02256\">$和誉-B(02256)$</a> 在产品管线推进与商业合作方面连续取得重大突破，获得国内外资本市场高度认可，先后被纳入明晟公司（MSCI）全球小盘股指数成分股和富时（FTSE）中国小盘股指数，多家权威机构陆续发布看好报告！\n小誉梳理了今年以来的机构评级，清一色“买入”、“增持”、“跑赢大市”等积极评价～资本市场一致看好，未来可期！\n<img src=\"https://static.tigerbbs.com/39c4c957e073c98b90e7a378266e1202\" tg-width=\"5760\" tg-height=\"3240\">\n<a href=\"https://laohu8.com/S/02256\">$和誉-B(02256)$</a></body></html>","text":"自年初以来， $和誉-B(02256)$ 在产品管线推进与商业合作方面连续取得重大突破，获得国内外资本市场高度认可，先后被纳入明晟公司（MSCI）全球小盘股指数成分股和富时（FTSE）中国小盘股指数，多家权威机构陆续发布看好报告！ 小誉梳理了今年以来的机构评级，清一色“买入”、“增持”、“跑赢大市”等积极评价～资本市场一致看好，未来可期！ $和誉-B(02256)$","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/481938303836936","repostId":0,"isVote":1,"tweetType":1,"viewCount":50853,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02256"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":309,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}